Related Experiment Video

Updated: Aug 29, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells

Leena Lindstedt1, Miriam Lee, Katariina Oörni

  • 1Wihuri Research Institute, Helsinki, Finland.

Insights

Cathepsins F and S degrade high-density lipoproteins (HDL) and apoA-I, impairing cholesterol removal. This suggests cathepsins promote foam cell formation in atherosclerosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cardiovascular Research

Background:

  • Atherosclerosis involves cholesterol accumulation in macrophages.
  • Defective cholesterol removal by high-density lipoproteins (HDL) contributes to this accumulation.
  • The role of specific cathepsins in HDL function and cholesterol efflux is not fully understood.

Purpose of the Study:

  • To investigate the proteolytic effects of cathepsins F, S, and K on HDL and apoA-I.
  • To determine the consequence of cathepsin activity on cholesterol efflux from macrophages.
  • To elucidate the potential role of cathepsins in foam cell formation in atherosclerosis.

Main Methods:

  • In vitro incubation of HDL(3) and lipid-free apoA-I with cathepsins F, S, and K.
  • Measurement of prebeta-HDL levels.
  • Assessment of cholesterol efflux from cholesterol-loaded mouse peritoneal macrophages.

Main Results:

  • Cathepsin F or S rapidly degraded HDL(3), reducing cholesterol efflux by 50% within 1 minute.
  • Cathepsins F or K partially degraded apoA-I, diminishing its cholesterol efflux-inducing capacity.
  • Cathepsin S completely degraded apoA-I, abolishing its cholesterol acceptor function.

Conclusions:

  • Cathepsin-secreting cells rapidly deplete lipid-poor HDL (prebeta-HDL) and lipid-free apoA-I.
  • Inhibition of cellular cholesterol efflux by cathepsins promotes foam cell formation and maintenance in atherosclerotic lesions.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...